Invention Grant
US09345754B2 Allogeneic tumor therapeutic agent, a vaccine using allogeneic tumor cells for the therapeutic treatment of tumor diseases, and a method for the making of such a vaccine, and transfected human tumor cells for use as a vaccine
有权
同种异体肿瘤治疗剂，使用同种异体肿瘤细胞用于治疗肿瘤疾病的疫苗，以及制备这种疫苗的方法，以及用作疫苗的转染的人肿瘤细胞
- Patent Title: Allogeneic tumor therapeutic agent, a vaccine using allogeneic tumor cells for the therapeutic treatment of tumor diseases, and a method for the making of such a vaccine, and transfected human tumor cells for use as a vaccine
- Patent Title (中): 同种异体肿瘤治疗剂，使用同种异体肿瘤细胞用于治疗肿瘤疾病的疫苗，以及制备这种疫苗的方法，以及用作疫苗的转染的人肿瘤细胞
-
Application No.: US12614985Application Date: 2009-11-09
-
Publication No.: US09345754B2Publication Date: 2016-05-24
- Inventor: Tomislav Dobric , Burghardt Wittig , Manuel Schmidt
- Applicant: Tomislav Dobric , Burghardt Wittig , Manuel Schmidt
- Applicant Address: DE Berlin
- Assignee: Mologen AG
- Current Assignee: Mologen AG
- Current Assignee Address: DE Berlin
- Agency: 24IP Law Group
- Agent Timothy R DeWitt
- Priority: WOPCT/DE03/04299 20031230
- Main IPC: A61K39/00
- IPC: A61K39/00 ; C12N5/09
Abstract:
A vaccine on the basis of allogeneic tumor cells for the therapeutic treatment of defined tumor diseases, and a method for the making of such vaccine is disclosed. The tumor cells were previously transfected ex vivo with expression constructs encoding cytokines and co-stimulatory factors.
Public/Granted literature
Information query
